JUPITER Trial and Diabetes: The JUPITER trial, which was terminated prematurely after less than two years, was widely heralded for showing that statins reduce the risk of heart attacks in the short term for people with high levels of C-reactive protein but without high cholesterol.
However, little note was made of the fact that the JUPITER trial also showed a 25 percent increased risk to new-onset diabetes in the treatment group. Since diabetes is a strong risk factor for heart disease, one wonders how the trial would have turned out if it had been allowed to run to completion.
No comments:
Post a Comment